Dimed S.A. Distribuidora de Medicamentos Stock Forecast for 2023 - 2025 - 2030
Updated on 03/29/2024
Dimed S.A. Distribuidora de Medicamentos Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Dimed S.A. Distribuidora de Medicamentos, with an average price target of R$16.25. This potential gain of 36.55 percent from the previous closing price in March, 2024 is calculated on a high forecast of R$23.00 and a low estimate of R$14.00. If you're interested in PNVL3 stock, it's important to compare it to other companies in the industry.
36.55% Upside
Dimed S.A. Distribuidora de Medicamentos Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Dimed S.A. Distribuidora de Medicamentos has seen a decline in its Price, from R$9.80 to R$0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of R$25.35, which would mean an increase of 100.00%. Over the next seven years, experts predict that Dimed S.A. Distribuidora de Medicamentos's Fair Value will grow at a rate of 100.00%.
Dimed S.A. Distribuidora de Medicamentos Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Dimed S.A. Distribuidora de Medicamentos's Revenue has grown by 41.55%, rising from R$2.82B to R$3.99B. According to the 0 analysts polled, in the next year, Dimed S.A. Distribuidora de Medicamentos's Revenue will fall by 16.98%, reaching R$3.31B. By 2030, professionals believe that Dimed S.A. Distribuidora de Medicamentos's Revenue will have decreased by 15.46%, falling to R$3.37B.
Dimed S.A. Distribuidora de Medicamentos Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, Dimed S.A. Distribuidora de Medicamentos's Dividend per Share has grown, rising from R$0.14 to R$0.17 – a growth of 21.43%. In the next year, analysts believe that Dividend per Share will reach R$0.46 – an increase of 170.59%. For the next seven years, the forecast is for Dividend per Share to grow by 161.61%.
Dimed S.A. Distribuidora de Medicamentos EBITDA Forecast for 2023 - 2025 - 2030
Dimed S.A. Distribuidora de Medicamentos's EBITDA has seen impressive growth In the last two years, rising from R$118.83M to R$180.29M – a growth of 51.72%. In the next year, analysts believe that EBITDA will reach R$358.67M – an increase of 98.94%. For the next seven years, the forecast is for EBITDA to grow by 153.98%.
Dimed S.A. Distribuidora de Medicamentos EBIT Forecast for 2023 - 2025 - 2030
In the last year, Dimed S.A. Distribuidora de Medicamentos's EBIT has grown by 12.39%, rising from R$91.45M to R$102.78M. For the next year, analysts predict that EBIT will reach R$267.50M – an increase of 160.26%. Over the next seven years, experts believe that Dimed S.A. Distribuidora de Medicamentos's EBIT will grow at a rate of 157.86%.
Dimed S.A. Distribuidora de Medicamentos EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Dimed S.A. Distribuidora de Medicamentos has seen a decline in its EPS, from R$0.46 to R$0.00 – a 100.00% decrease. For next year, analysts predict EPS of R$1.19, which would mean an increase of 100.00%. Over the next seven years, experts predict that Dimed S.A. Distribuidora de Medicamentos's EPS will grow at a rate of 100.00%.